GlassScriptPhysician profile
Laura M Chavez
NPI 1326136417
$1,721.36
in general payments reported to CMS, 2019-2025
22 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $13.64 · 2021: $28.74 · 2022: $295 · 2023: $535 · 2024: $246 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $398.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $227.08 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $155.61 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $151.86 | 2022-2025 | Vraylar, Linzess, Viberzi |
| Janssen Pharmaceuticals, INC | $122.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.66 | 2019-2024 | Xifaxan, Trulance |
| Abbott Laboratories | $91.01 | 2022-2024 | Freestyle Libre, Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $77.95 | 2022-2023 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $72.93 | 2024-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $61.35 | 2021-2023 | |
| Medtronic, INC. | $58.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.01 | 2019-2025 | Jardiance |
| Dexcom, INC. | $23.62 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $18.62 | 2024 | |
| Sanofi-Aventis U.S. LLC | $16.83 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $16.73 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.05 | 2022 | |
| Merck Sharp & Dohme LLC | $15.00 | 2019 | |
| Genentech USA, INC. | $14.87 | 2022 | |
| Tactile Systems Technology INC | $14.03 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.85 | 2019 | |
| Allergan, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.